RxDoctor Payments Data

Melanie Priebe, PA

Physician Assistant · Moosic, PANPI 1255417861

Payments from drug & device makers

$6,770in general payments, 2019–2025

Across 435 payments — averaging $15.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$655
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$588
  • Takeda Pharmaceuticals U.S.A., Inc.$559
  • AbbVie$546
  • Johnson & Johnson$487
  • Neurocrine Biosciences, Inc.$402
  • plus $4K from 23 others

What the payments were for

  • Food & beverage$6,61298%
  • Education$1582%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,770 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$33,741
Medicare patients
84
Services billed
398

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine20$92,429
SpravatoEsketamine Hcl32$51,460
VraylarCariprazine Hcl35$49,484
RexultiBrexpiprazole15$21,420
NuedextaDextromethorphan Hbr/Quinidine13$19,739
Aripiprazole123$12,776
Methylphenidate ErMethylphenidate Hcl20$5,192
Risperidone123$2,505
Lurasidone Hcl44$2,379
Clonazepam248$2,272
Paliperidone ErPaliperidone14$2,271
Divalproex Sodium38$2,267
Fluoxetine Hcl121$1,611
Bupropion XlBupropion Hcl48$1,568
Duloxetine Hcl63$1,454

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$655$92,42920 claims
Johnson & JohnsonSpravato$487$51,46032 claims
AbbVieVraylar$546$49,48435 claims
Otsuka America Pharmaceutical, Inc.Rexulti$319$21,42015 claims
Avanir Pharmaceuticals, Inc.Nuedexta$25$19,73913 claims
Almatica Pharma LLCSertraline Hcl$238$99676 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Moosic

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →